Acerus to Report Second Quarter 2019 Financial Results and Host Investor Call

TORONTO--()--Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2019 financial and operating results on Wednesday, August 7, 2019 before the market opens. The company will also host a conference call on Wednesday, August 7, 2019 at 8:30 a.m. Eastern Time.

To access the call live, please dial 416-204-1547 or 1-866-215-0058. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Wednesday, August 14, 2019 by dialing 905-694-9451 or 1-800-408-3053, using access code: 2038837#.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.

Acerus’ shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.

Contacts

Robert Motz
Chief Financial Officer
rmotz@aceruspharma.com
(905) 817-8288

Social Media Profiles

Contacts

Robert Motz
Chief Financial Officer
rmotz@aceruspharma.com
(905) 817-8288